Debt Management: Stryker's debt-to-equity ratio is notably higher than the industry average. With a ratio of 0.76, the ...

As of Tuesday morning, Corcept Therapeutics shares are down by 0.59%, with a current price of $79.35. This implies that Belanoff's 550,000 shares have a value of $41,508,500.

Options give investors the right, but not the obligation, to buy shares with a call or sell them with a put. Deciding whether to exercise or hold an option depends on factors like remaining time value ...

Daniel Nathan and Brian Neil Hoffman of Morrison & Foerster write: Stock option exercises may create additional risks of violating the securities laws depending upon how they are exercised. Through ...

Many foreign persons are employed in America and are given stock options as an incentive by the companies for which they work. When a foreign national works in the U.S. and is granted stock options, ...

Focused on rare liver disease therapies, this biopharma company reported a significant insider sale amid strong one-year stock gains.

Highlighted on May 7, it was unveiled in an SEC filing that Sutton, Director at Ameresco (NYSE:AMRC), executed a significant transaction involving the exercise of company stock options. What Happened: ...

Stock options became common parlance in venture-funded startups in the mid-70s when struggling startups succeeded in attracting the talent and interest of their employees by offering them stock ...

SoFi Technologies (SOFI) was trading lower after an announcement on the exercise of underwriters' option to purchase shares ...